News And Announcements
FCA still investigating RBS's GRG over SME issues
The City watchdog has published an interim report into the treatment by Royal Bank of Scotland small business clients, though it said the bank remained under investigation over some unnamed matters that could see further regulatory action.
Smith & Nephew acquires 'game changing' shoulder surgery technology
Smith & Nephew has agreed to snap up a US developer of a "game changing" surgical technology that helps speed the healing process in rotator cuff shoulder injuries.
Spire Healthcare rebuffs offer from Mediclinic, analysts expect more
Spire Healthcare has rejected a cash-and-shares offer from fellow private hospital operator Mediclinic International that has been described by analysts as "opportunistic".
Pendragon warns on profit amid weaker new car demand
Car dealership Pendragon warned on Monday that full-year profit will be hit by weaker new car demand and pricing on used cars, as it announced that chairman Mel Egglenton has stepped down with immediate effect.
FCA fines Merrill Lynch for failing to report 64m transactions
Merrill Lynch International has been hit with a large fine by the City watchdog for failing to report details of millions of financial transactions.
Real Good Food warns of full-year loss
Baking ingredients business Real Good Food warned on Monday that it will report a loss for the year as higher costs and currency movements take their toll.
Government's new housebuilding plans 'could end cosy climate for builders'
The government has proposed a major state housebuilding push to ease the housing crisis, with one side-effect being an end to the "cosy and golden trading climate" that large building companies currently enjoy.
Arqiva announces plans for London listing
Broadcast and mobile masts company Arqiva has announced its intention to float on the London Stock Exchange in a £6bn listing.
Essentra returns to revenue growth, but profits hit by hurricanes
In the third quarter Essentra returned to like-for-like revenue growth for the first time in almost two years, though full year margins for the plastics and packaging group will be dented by the impact of Hurricane Maria on its Puerto Rico sites.
Clinigen buys Japanese medicine supplier
AIM-listed pharmaceutical and services company Clinigen has acquired International Medical Management Corporation (IMMC), Japan's largest supplier of unlicensed medicines, for an undisclosed sum.
Petra revenue and production drop on diamonds seizure, labour disruptions
Petra Diamonds posted a 4% drop in production and a 17% decline in revenue for the first quarter.
Interserve secures £140m contract extension with BBC
Support services and construction group Interserve has won a £140m contract with the BBC to continue providing facilities services until 2023.
Capita's sale of Asset Services arm nears completion
Capita expects to complete the sale of its Asset Services businesses to Link Administration a week on Friday.
Electra Private Equity eyes new flexible approach, declares another dividend
After completing a strategic review and reverted to internal management of its investments, Electra Private Equity has decided "current market conditions do not support new investment" and so proposed handing back most of its cash and dropping its focus on private equity to become "more flexible".
CRH gets shareholder approval for Ash Grove deal
Building materials company CRH is set to push ahead with its $3. 5bn acquisition of US cement manufacturer Ash Grove Cement after receiving shareholder approval for the deal.
AstraZeneca diabetes drug gets FDA approval
AstraZeneca said that the US Food and Drug Administration has approved a new formulation of its type-2 diabetes treatment Bydureon.
GlaxoSmithKline's Shingrix gets US FDA approval
GlaxoSmithKline said on Monday that the US Food and Drug Administration has approved Shingrix for the prevention of shingles in adults over 50.
Renewi sees full-year results 'significantly above' previous expectations
Waste-to-product business Renewi said on Monday that results for the year are expected to be “significantly above” its previous expectations following a particularly strong performance in September.